Mitora™D+Q is a research-grade senolytic compound combination of Dasatinib and Quercetin, widely used in aging, cellular biology, and preclinical studies. This synergistic formulation is designed to selectively target and eliminate senescent cells, providing reproducible results for in vitro and experimental research.
Technical Specifications
Copyright©2023 Mitora™
Powered by Mitora™